QuidelOrtho Corporation
QDEL
Clasificación en acciones
#9368
QuidelOrtho Corporation specializes in the creation and production of... QuidelOrtho Corporation specializes in the creation and production of diagnostic testing solutions, addressing a wide array of healthcare testing demands. The company operates through distinct business units. Its Labs division provides clinical chemistry and immunoassay instruments and tests designed to analyze bodily fluids and proteins, aiding in health assessment, patient management, and tracking disease progression. The Transfusion Medicine unit focuses on ensuring blood safety and compatibility by offering immunohematology and infectious disease screening tests for blood and plasma. For rapid results in various clinical environments, the Point-of-Care segment delivers quick diagnostic tests. Additionally, the Molecular Diagnostics arm develops advanced polymerase chain reaction thermocyclers, analyzers, and amplification systems. QuidelOrtho distributes its offerings both directly to end-users and through an extensive network of distributors. These products are utilized by professionals in settings such as medical offices, hospitals, clinical and reference laboratories, urgent care centers, universities, retail clinics, pharmacies, wellness screening centers, and blood/donor banks, as well as for individual, non-professional, and over-the-counter applications. Founded in 1979 and based in San Diego, California, the company maintains a global footprint, including operations across North America, Europe, the Middle East, Africa, and China.
Precio por acción
$14.24
Capitalización bursátil
$976.51M
Cambio (1 día)
11.60%
Cambio (1 año)
-66.95%
País
US
Comercio QuidelOrtho Corporation (QDEL)
Categoría
Healthcare
Ganancias de QuidelOrtho Corporation (QDEL)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di QuidelOrtho Corporation, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de QuidelOrtho Corporation desde 2026 hasta 2026
Ganancias al final de cada año
| Año | Ganancias | Cambiar |
|---|---|---|
| Not enough data for the provided dates. | ||
Ganancias de empresas similares o competidoras
| Empresa | Ganancias | Diferencia de ganancias | País |
|---|---|---|---|
| $3.81B | - |
US
|
|
| $4.11B | - |
FR
|
|
| - | - |
JP
|
|
| $1.59B | - |
US
|
|
| - | - |
CH
|
